[Updated 12/6/17 11:43 a.m. See below.] Retailers across the U.S. often hire additional workers this time of year to help get them through the busy holiday shopping season. Allowing employers to bring in extra help during busy times is... Read more »
Author, investor, and AOL co-founder Steve Case today announced a new $150 million venture fund aimed at pumping investment capital into tech companies in so-called flyover states. Contributing to the fund is an impressive group of some of the most successful... Read more »
Many of biotech’s biggest stories in 2017 followed the highly anticipated data from clinical studies. There were monumental successes, like the first-ever approval of a genetically modified living cell therapy, the first FDA application for a gene therapy or a... Read more »
Stay current on the latest news from Wisconsin’s innovation community with these recent headlines:
—Stonehouse Water Technologies, a Milwaukee-based startup developing energy-efficient water purification systems, said it raised more than $1.5 million from investors. Launched in 2012, Stonehouse is developing a... Read more »
A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency of headaches.
These drugs still await an FDA decision, and their impact on patients over the long term... Read more »
Artificial intelligence holds promise for healthcare in areas like radiology, but it could be tough sledding for businesses selling narrowly focused products to one customer at a time. The winners in this emerging sector will figure out how to integrate A.I.... Read more »
Local startup companies could be among the beneficiaries of a 25 million-square-foot manufacturing facility that Foxconn, a Taiwanese electronics assembly giant, intends to build in southeastern Wisconsin, according to state economic development officials.
Foxconn, which is perhaps best known as a... Read more »
If Wednesday’s hearing for Health and Human Services Secretary Nominee Alex Azar is any indication, reining in drug prices and insurance premiums are the policy priorities that will guide Congress’s interaction with the department under a new leader.
For the better... Read more »
Shares in Exact Sciences have more than quadrupled in 2017, and the stock’s impressive run has led some analysts to question whether it’s a smart buy at the current price. But Jeff Elliott, Exact’s chief financial officer, says he believes his... Read more »